Analystreport

Clearside Biomedical Inc (NASDAQ: CLSD) is now covered by analysts at Laidlaw. They set a "buy" rating and a $18.00 price target on the stock.

Clearside Biomedical, Inc.  (CLSD) 
Last clearside biomedical, inc. earnings: 3/11 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.clearsidebio.com/investor-overview